Session Type
Meeting
Search Results for Anticoagulation
Abstract Number: B9
SHM Converge 2022
Background: Patients with end stage renal disease (ESRD) are at significantly increased risk for both thrombosis and bleeding relative to those with normal renal function, which makes anticoagulation particularly challenging. Evidence suggests that rivaroxaban and dabigatran are associated with a higher risk of bleeding in ESRD patients. To date, no large national cohort studies have […]
Abstract Number: B28
SHM Converge 2022
Case Presentation: A 51-year-old female with no significant medical history presented to the hospital after a ground-level fall with severe thoracic back pain, paresthesia, paresis of both lower extremities and urinary incontinence. Exam revealed thoracic spine tenderness, bilateral diminished sensation up to two inches above the umbilicus and 1/5 bilateral lower extremity strength. Spinal MRI […]
Abstract Number: I27
SHM Converge 2022
Case Presentation: A 46-year-old white male with a history of prior MI (at age 37) presented to ED with left-sided weakness, facial droop, and decreased left-arm sensation. He did not have a history of obesity, hypertension, smoking, excess alcohol consumption, or hyperlipidemia but had a family history of a sister who had a stroke in […]
Abstract Number: I32
SHM Converge 2022
Case Presentation: 56-year-old woman with past medical history of hypertension, cerebrovascular accident, coronary artery disease, atrial fibrillation on apixaban presented with worsening left arm weakness. Patient was on full dose anticoagulation with apixaban 5 milligram(mg) every 12 hours and antiplatelet therapy with aspirin 81 mg. On physical examination patient had ischemic left upper extremity. Computed […]
Abstract Number: L34
SHM Converge 2022
Case Presentation: A 82-year-old male patient with a past medical history of Coronary Artery Bypass Graft (CABG) and severe mitral regurgitation with repair presented at 6 weeks after bioprosthetic mitral valve replacement with a two-day history of sudden onset of dyspnea, that was associated with exertion and orthopnea. Vitals upon evaluation were as follows: Initial […]
Abstract Number: L48
SHM Converge 2022
Case Presentation: Implanted central venous port catheters (ports) are widely used for chemotherapy, total parenteral nutrition and blood monitoring. If placed in the subclavian vein, up to 15% of patients who receive implanted ports have immediate complications, including venous injury, pneumothorax and pneumomediastinum. Long-term ports are associated with delayed complications, including thrombosis, occurring in 1.9-21.5% […]
Abstract Number: M23
SHM Converge 2022
Background: Symptomatic venous thromboembolism (VTE) occurs in about 1% of patients within 3 months after admission to a medicine ward.1,2 The 9th Edition American College of Chest Physicians Guidelines recommends the use of pharmacologic VTE prophylaxis in acutely ill hospitalized medical patients at increased risk of thrombosis and suggests against its use in low risk […]